Impact of Magnetic Stimulation on Pain in Endometriosis Patients

ConditionEndometriosis
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorKantonsspital Winterthur KSW

About this trial

Many women with endometriosis still experience pain despite surgical and medical treatment. Over-the-counter painkillers are usually helpful in alleviating this pain. But for some patients, these medications eventually stop working. Pain then dominates their daily life. In this study, we are investigating the effects of magnetic stimulation using the "Tesla chair" and whether it can alleviate their pain

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patient has been informed about study

Age ≥ 18 years

Premenopausal

histologically or laparoscopically or MRI confirmed endometriosis

Disqualifiers

Contraindications according manufactureres manual Tesla Chair

Pregnancy or desire to become pregnant within the next 8 weeks

Pelvic organ prolapses

Genital infections

Trial design

Design model

Single group

Treatments tested in this trial

  • Magnetic stimulation

    Device

    Magnetic stimulation using the Tesla-Chair

Treatment groups

30 Participants
are divided into 1 treatment group
Group A: Tesla-ChairExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Decrease of PPAF-Score before and after treatment.

Relief of pain measured by changes in PPAF (Pelvic pain assessment form) score before and after the treatment. 0= no pain, 10 = unbearable pain

Time frame
From enrollment to the end of tratment at end of week 7

Secondary outcomes

1

Decrease of PPAF-Score before and after treatment.

Relief of pain measured by changes in PPAF (Pelvic pain assessment form) score before and after the treatment. 0= no pain, 10 = unbearable pain

Time frame
From enrollment to 3 months after completion of treatment

Other outcomes

1

Subjective experience of patients, decrease in analgetic use

Subjective experience of patients, decrease in analgetic use, subjective success

Time frame
From enrollment to 3 months after completion of treatment

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: